MedPath

The effect of Melatonin on Delirium Preventio

Phase 3
Conditions
Delirium.
Other delirium
F05.8
Registration Number
IRCT20190419043320N1
Lead Sponsor
Kashan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
72
Inclusion Criteria

All patients over the age of 60 under hip, femure or knee surgery
Surgery under spinal anesthesia

Exclusion Criteria

Drug abuse
Dementia
Sensory loss including blindness and deafness
Epilepsy

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Delirium. Timepoint: At the beginning of the study and T the first, second and third days after the intervention. Method of measurement: MMT Test Questionnaire.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath